Fulgent Genetics Inc
FLGT - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$567.37M
Close$
$7.05
63.5% downside
Current Fair Value
63.5% downsideOvervalued by 63.5% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $567.37 Million |
|---|---|
| Enterprise Value | $680.92 Million |
| Earnings per Share | $-1.97 |
| Beta | 0.93 |
| Outstanding Shares | 28,005,000 |
Return
| Return on Equity | -8.42% |
|---|---|
| Return on Assets | -7.75% |
| Return on Invested Capital | -9.99% |
Valuation & Multiples
| P/E Ratio | -7.31 |
|---|---|
| PEG | -13.11 |
| Price to Sales | 1.75 |
| Price to Book Ratio | 0.55 |
| Enterprise Value to Revenue | 2.1 |
| Enterprise Value to EBIT | -6.7 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0.21 |
| Debt to Equity | 0.14 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 7, 2026
EPS Estimate
$-0.26
Consensus analyst estimateRevenue Estimate
$89.95 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.65
Consensus analyst estimateRevenue Estimate
$86.30 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 11.26% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.23%▼ 50.73% |
|---|---|
| Total Invested | $7.60M▼ 97.69% |
| Investors Holding | 26▼ 121.00% |
About Fulgent Genetics Inc
429 employees
CEO: Ming Hsieh
Fulgent Genetics' proprietary technology platform has created a broad, flexible test menu and the ability to continually expand and improve its proprietary genetic reference library while maintaining accessible pricing, high accuracy and...